Biosimilars for the Treatment of IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease
Inflamm. Bowel Dis. 2022 Dec 01;28(12)1915-1923, SA Patil, S Bhat, JK Limdi, FA Farraye, RK CrossFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.